100
Participants
Start Date
March 31, 2002
Primary Completion Date
August 31, 2004
Study Completion Date
August 31, 2004
abacavir/lamivudine/zidovudine
tenofovir
GSK Investigational Site, New York
GSK Investigational Site, The Bronx
GSK Investigational Site, Valhalla
GSK Investigational Site, Decatur
GSK Investigational Site, Atlanta
GSK Investigational Site, Jacksonville
GSK Investigational Site, Tallahassee
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Miami Beach
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, North Miami
GSK Investigational Site, Lake Worth
GSK Investigational Site, Lafayette
GSK Investigational Site, Berkeley
GSK Investigational Site, Green Bay
GSK Investigational Site, Maywood
GSK Investigational Site, Chicago
GSK Investigational Site, Tulsa
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Arlington
GSK Investigational Site, Houston
GSK Investigational Site, Los Angeles
GSK Investigational Site, San Rafael
GSK Investigational Site, Seattle
Lead Sponsor
ViiV Healthcare
INDUSTRY